Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Current Quarter	$3.74	Next Quarter	$4.1
Current Year	$17.04	Next Year	$18.98
QoQ Growth	+9.6%	YoY Growth	+11.4%
3Y EPS CAGR	+37.2%	Target Price	$506.42
Consensus	Buy	Upside	+2.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$492.44	-1.81%	131.79K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MEDP	$492.44	-1.8%	131.79K
3
4
5
6

MEDP

MEDP

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Medpace Holdings Inc. Data in Excel

Get Medpace Holdings Inc. Data in Excel